financetom
Business
financetom
/
Business
/
Pfizer CEO plans to meet activist investor Starboard Value, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer CEO plans to meet activist investor Starboard Value, FT reports
Oct 10, 2024 9:39 PM

(Reuters) - Pfizer ( PFE ) CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter.

Bourla and at least one other director will hold talks with Starboard next week, the report said.

Pfizer ( PFE ) declined to comment, while Starboard Value did not immediately respond to a Reuters request for comment.

Reuters reported on Sunday, citing sources, that Starboard Value has taken a stake of about $1 billion in Pfizer ( PFE ) and wants the U.S. drugmaker to make changes to turn its performance around.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brinker International Insider Sold Shares Worth $2,421,023, According to a Recent SEC Filing
Brinker International Insider Sold Shares Worth $2,421,023, According to a Recent SEC Filing
May 14, 2024
05:56 PM EDT, 05/14/2024 (MT Newswires) -- Joseph G Taylor, Executive Vice President & CFO, on May 13, 2024, sold 40,050 shares in Brinker International ( EAT ) for $2,421,023. Following the Form 4 filing with the SEC, Taylor has control over a total of 66,286 shares of the company, with 66,286 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/703351/000095017024059815/xslF345X03/ownership.xml ...
Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment
Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment
May 14, 2024
05:57 PM EDT, 05/14/2024 (MT Newswires) -- Nanobiotix ( NBTX ) said Tuesday the US Food and Drug Administration accepted the protocol for a randomnized phase 2 study evaluating NBTXR3 for the treatment of patients with stage 3, unresectable non-small cell lung cancer. The biotechnology company also said the global trial sponsor, Johnson & Johnson Enterprise Innovation, a unit of...
EV startup Canoo posts larger-than-expected loss in first quarter
EV startup Canoo posts larger-than-expected loss in first quarter
May 14, 2024
May 14 (Reuters) - Electric vehicle startup Canoo ( GOEV ) posted a larger-than-expected loss for the first quarter on Tuesday, but kept its outlook for the year unchanged. Slowing demand in the United States and stiff competition from Chinese EV makers in the world's largest auto market has hit demand for companies including Canoo ( GOEV ). That has...
Petco Health & Wellness Appoints Glenn Murphy as Executive Chairman; Shares Rise After Hours
Petco Health & Wellness Appoints Glenn Murphy as Executive Chairman; Shares Rise After Hours
May 14, 2024
05:57 PM EDT, 05/14/2024 (MT Newswires) -- Petco Health & Wellness (WOOF) said late Tuesday it named Glenn Murphy as executive chairman of the board, effective immediately. As part of his appointment, Murphy purchased 1.47 million Petco class A common shares for $2.5 million, the company said. Murphy currently serves as chief executive officer of consumer-focused investment firm FIS Holdings....
Copyright 2023-2025 - www.financetom.com All Rights Reserved